Effect of Heated Breathing Circuit on Intraoperative Core Temperature and Systemic Inflammation After Brain Surgery: a Prospective Randomized Study

March 14, 2019 updated by: Yonsei University
Mechanical respiration during general anesthesia causes cold and dry gases to reach the lower airway, reduce the function of the airway mucosa, and cause accumulation of secretions. Inhaled dry gas is one of the causes of hypothermia during general anesthesia. To overcome this, the warm-humidifying breathing circuit uses warm, moisture-preserving gas to promote mucus mobility of the airway mucosal ciliate cells and prevents cold gases from evaporating from the mucosal surfaces which results lowering body temperature. We aimed to investigate the effect of newly developed Sohum warm humidifying respiration circuit (SH501) on the prevention of core body temperature reduction during surgery and systemic inflammation reaction.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

117

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Yong Seon Choi, MD
  • Phone Number: +82-2-2228-2428
  • Email: yschoi@yuhs.ac

Study Locations

      • Seoul, Korea, Republic of, 03722
        • Recruiting
        • Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institue, Yonsei Universiy College of Medicine
        • Contact:
          • Yong Seon Choi, MD, Ph.D
          • Phone Number: +82-2-2227-4966
          • Email: yschoi@yush.ac

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. age ≥ 19
  2. scheduled for brain surgery

Exclusion Criteria:

  1. age < 19
  2. patients with severe obstructive lung disease and/or restrictive lung disease patients
  3. patients with infectious disease
  4. surgery with prone position or lateral position
  5. arrhythmia

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: group C
general circuit group

The patient enters the operating room without any pretreatment and attaches a standard patient monitoring device. Anesthesia was performed by intravenous anesthesia. After induction of anesthesia, alveolar recruitment is performed in supine position in all groups with 30 cmH2O for 5 seconds. Mechanical ventilator was set with tidal volume of 8 ml / kg, the inspiratory/ expiratory ratio of 1: 2 and respiratory rate was adjusted for targeting EtCO2 around 35mmHg. Keep the fresh air flow of the ventilator at 3 L / min and set the temperature to 37 ° C for the heating circuits of group H and group SH. An arterial cannulation and subclavian jugular vein catheter is inserted.

The circuits were applied to each group as follows; conventional circuit or group C, conventional humidification circuit for group H and new humidification heat circuit for group SH, respectively. All other conditions were same among three groups.

Other Names:
  • group C for control group (n=39)
Active Comparator: group H
warm circuit group

The patient enters the operating room without any pretreatment and attaches a standard patient monitoring device. Anesthesia was performed by intravenous anesthesia. After induction of anesthesia, alveolar recruitment is performed in supine position in all groups with 30 cmH2O for 5 seconds. Mechanical ventilator was set with tidal volume of 8 ml / kg, the inspiratory/ expiratory ratio of 1: 2 and respiratory rate was adjusted for targeting EtCO2 around 35mmHg. Keep the fresh air flow of the ventilator at 3 L / min and set the temperature to 37 ° C for the heating circuits of group H and group SH. An arterial cannulation and subclavian jugular vein catheter is inserted.

The circuits were applied to each group as follows; conventional circuit or group C, conventional humidification circuit for group H and new humidification heat circuit for group SH, respectively. All other conditions were same among three groups.

Other Names:
  • group H for conventional humidification circuit (n = 39)
Experimental: group SH
new warm circuit group

The patient enters the operating room without any pretreatment and attaches a standard patient monitoring device. Anesthesia was performed by intravenous anesthesia. After induction of anesthesia, alveolar recruitment is performed in supine position in all groups with 30 cmH2O for 5 seconds. Mechanical ventilator was set with tidal volume of 8 ml / kg, the inspiratory/ expiratory ratio of 1: 2 and respiratory rate was adjusted for targeting EtCO2 around 35mmHg. Keep the fresh air flow of the ventilator at 3 L / min and set the temperature to 37 ° C for the heating circuits of group H and group SH. An arterial cannulation and subclavian jugular vein catheter is inserted.

The circuits were applied to each group as follows; conventional circuit or group C, conventional humidification circuit for group H and new humidification heat circuit for group SH, respectively. All other conditions were same among three groups.

Other Names:
  • group SH for new humidifaction heat circuit (n=39)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
core temperature
Time Frame: every 30 minute after induction of anesthesia until the end of anesthesia
every 30 minute after induction of anesthesia until the end of anesthesia
upper airway temperature
Time Frame: every 30 minute after induction of anesthesia until the end of anesthesia
every 30 minute after induction of anesthesia until the end of anesthesia
upper airway humidity
Time Frame: every 30 minute after induction of anesthesia until the end of anesthesia
every 30 minute after induction of anesthesia until the end of anesthesia

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
cytokine level
Time Frame: 1, 30, 60, 90, 120, 150, 180, 210, 240 minute after induction and 1 second after the operation
pg/ml for Cytokine level(TNF-a, IL-1, IL-6, IL-8, IL-10)
1, 30, 60, 90, 120, 150, 180, 210, 240 minute after induction and 1 second after the operation
dead space
Time Frame: every 30 minute after induction of anesthesia until the end of anesthesia
% for Deadspace(Vd/Vt)
every 30 minute after induction of anesthesia until the end of anesthesia
intrapulmonary shunt
Time Frame: every 30 minute after induction of anesthesia until the end of anesthesia
Qs/Qt,
every 30 minute after induction of anesthesia until the end of anesthesia
respiratory variables
Time Frame: every 30 minute after induction of anesthesia until the end of anesthesia
mmHg for respiratory variables(PaO2, PaCO2, PvO2, PvCO2)
every 30 minute after induction of anesthesia until the end of anesthesia
compliance
Time Frame: every 30 minute after induction of anesthesia until the end of anesthesia
L/cmH2O for compliance(△V/△P)
every 30 minute after induction of anesthesia until the end of anesthesia

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2018

Primary Completion (Anticipated)

January 1, 2020

Study Completion (Anticipated)

January 1, 2020

Study Registration Dates

First Submitted

March 8, 2018

First Submitted That Met QC Criteria

April 5, 2018

First Posted (Actual)

April 9, 2018

Study Record Updates

Last Update Posted (Actual)

March 18, 2019

Last Update Submitted That Met QC Criteria

March 14, 2019

Last Verified

March 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 1-2017-0087

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Patients Scheduled for Brain Surgery

Clinical Trials on conventional circuit

3
Subscribe